A Study to Assess Long-term Outcomes of Myocarditis Following Administration of COVID-19 mRNA Vaccine (SPIKEVAX)

Post-marketing Surveillance (PMS) Use-Result Surveillance With SPIKEVAX BIVALENT, SPIKEVAX X Injection, SPIKEVAX JN Injection and SPIKEVAX IN PRE-FILLED SYRINGE

NCT06333704 ·Status: ACTIVE_NOT_RECRUITING

The Long-term Antibody Persistence of GSK Biologicals' Meningococcal Vaccine GSK134612 in Healthy Toddlers

NCT00718666 ·Status: COMPLETED ·Phase: PHASE2

A Study to Learn About Bivalent COVID-19 RNA Vaccine Candidate(s) in Healthy Infants and Children

NCT05630352 ·Status: WITHDRAWN ·Phase: PHASE1

A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED)

NCT00092391 ·Status: COMPLETED ·Phase: PHASE3

To Assess Immunogenicity, Reactogenicity & Safety of 2 Formulations of GSK's HRV Vaccine as 2-dose Vaccination (Infants)

NCT00363545 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273.214 SARS-CoV-2 (COVID-19) Vaccine in Infants

NCT05584202 ·Status: TERMINATED ·Phase: PHASE2

Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines

NCT00463437 ·Status: COMPLETED ·Phase: PHASE3

A Study of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Diphtheria, Pertussis and Tetanus (Tdap) Viruses Followed by a 2nd Dose of the RSV Vaccine to Healthy Non-Pregnant Women

NCT04138056 ·Status: COMPLETED ·Phase: PHASE2

Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants

NCT01090453 ·Status: COMPLETED ·Phase: PHASE2

Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age

NCT00861744 ·Status: COMPLETED ·Phase: PHASE2

Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Healthy Infants

NCT01098474 ·Status: COMPLETED ·Phase: PHASE2

Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose

NCT01171989 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and Toddlers

NCT04535037 ·Status: COMPLETED ·Phase: PHASE4

Immunogenicity Study of the Japanese Encephalitis Vaccine IC51

NCT00604708 ·Status: COMPLETED ·Phase: PHASE3

Immuno,Safety of GSK Vaccine 134612 Given at Age of 12-15 Months 15-18 Months Post-priming With GSK Vaccine 792014

NCT00614614 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age).

NCT00352963 ·Status: COMPLETED ·Phase: PHASE3

A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age

NCT06855160 ·Status: RECRUITING ·Phase: PHASE3

Long-term Persistence Study to Assess a Booster Dose of GSK Biologicals' Hib-MenC

NCT00322335 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate GSK Biologicals' GSK2197870A Vaccine Given as Primary Course in Infants

NCT00871338 ·Status: COMPLETED ·Phase: PHASE2

Compare Immunogenicity & Safety of 2 Formulations of GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine Given in Healthy Infants

NCT00320463 ·Status: COMPLETED ·Phase: PHASE3

Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine at Different Viral Concentrations in Healthy Infants

NCT00429481 ·Status: COMPLETED ·Phase: PHASE2

Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants

NCT03621670 ·Status: COMPLETED ·Phase: PHASE3

Safety & Immunogenicity of Pneumococcal Vaccine 2189242A Co-administered With DTPa-HBV-IPV/Hib in Healthy Infants

NCT01204658 ·Status: COMPLETED ·Phase: PHASE2

Serologic Response to Porcine Circovirus Type 1 (PCV-1) in Infants Following Administration of Rotarix™

NCT02153333 ·Status: COMPLETED

Evaluation of Long-Term Immunogenicity in Subjects Boosted With a TBE Vaccine for Adults

NCT00311493 ·Status: COMPLETED ·Phase: PHASE4